Wednesday, April 22

Browsing: Eftilagimod

Treatments

Investigators to Discontinue Trial of Eftilagimod Alfa in Frontline NSCLC

By NewsCancerMarch 16, 20260

Investigators will discontinue their assessment of eftilagimod alfa (efti) in combination with pembrolizumab (Keytruda) and chemotherapy among patients with first-line…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial

Work, Money, & a Normal Life

AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires

Browsing: Eftilagimod

Investigators to Discontinue Trial of Eftilagimod Alfa in Frontline NSCLC

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial

Work, Money, & a Normal Life

AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires

HDAC8 inhibition targets STAT3–MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial

Work, Money, & a Normal Life

AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires

HDAC8 inhibition targets STAT3–MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia

Latest Post

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial

Work, Money, & a Normal Life

AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires

Subscribe to Updates

What's Hot

Browsing: Eftilagimod